In response to Dr. Knisely and colleagues

Vinai Gondi; Ranjini Tolakanahalli; Minesh P. Mehta; Wolfgang A. Tomé

doi:10.1016/j.ijrobp.2010.10.044

In response to Dr. Knisely and colleagues

Vinai Gondi
, Ranjini Tolakanahalli
, Minesh P. Mehta
, Wolfgang A. Tomé

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	958
Number of pages	1
Journal	International Journal of Radiation Oncology Biology Physics
Volume	79
Issue number	3
DOIs	https://doi.org/10.1016/j.ijrobp.2010.10.044
State	Published - Mar 1 2011
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Radiation
Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

Access to Document

10.1016/j.ijrobp.2010.10.044

Cite this

@article{cbe522e712b54fcb88793afe3fff8fc5,

title = "In response to Dr. Knisely and colleagues",

author = "Vinai Gondi and Ranjini Tolakanahalli and Mehta, \{Minesh P.\} and Tom{\'e}, \{Wolfgang A.\}",

note = "Funding Information: Disclosures: Dr. Mehta has served as a consultant to Adnexus, Bayer, Genenteh, Merck, Schering Plough, and Tomotherapy; he serves on the Board of Directors of Pharmacyclics and as an advisor to Stemina, and is on the DSMB for Apogenix. He holds stock options in Pharmacyclics and Tomotherapy. Dr. Tome holds a research grant from Philips Radiation Oncology Systems and serves on the Scientific Advisory Board of Viewray, Inc . ",

year = "2011",

month = mar,

day = "1",

doi = "10.1016/j.ijrobp.2010.10.044",

language = "English (US)",

volume = "79",

pages = "958",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - In response to Dr. Knisely and colleagues

AU - Gondi, Vinai

AU - Tolakanahalli, Ranjini

AU - Mehta, Minesh P.

AU - Tomé, Wolfgang A.

N1 - Funding Information: Disclosures: Dr. Mehta has served as a consultant to Adnexus, Bayer, Genenteh, Merck, Schering Plough, and Tomotherapy; he serves on the Board of Directors of Pharmacyclics and as an advisor to Stemina, and is on the DSMB for Apogenix. He holds stock options in Pharmacyclics and Tomotherapy. Dr. Tome holds a research grant from Philips Radiation Oncology Systems and serves on the Scientific Advisory Board of Viewray, Inc .

PY - 2011/3/1

Y1 - 2011/3/1

UR - https://www.scopus.com/pages/publications/79551493087

UR - https://www.scopus.com/pages/publications/79551493087#tab=citedBy

U2 - 10.1016/j.ijrobp.2010.10.044

DO - 10.1016/j.ijrobp.2010.10.044

M3 - Letter

AN - SCOPUS:79551493087

SN - 0360-3016

VL - 79

SP - 958

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 3

ER -

In response to Dr. Knisely and colleagues

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this